MEMBER PREVIEW
Nine industry chairs called for quicker clinical approvals, more research spending, firmer intellectual-property protection and fiscal flexibility to compete with the US and China.
FREE MEMBER LOGIN
LOGIN TO CONTINUE READING.
Create or use your free IMG login to read standard articles. Important and Premium analysis also requires an active ₹99 or ₹199 plan.
The public preview and the member article share the same canonical page. No personalised investment recommendation is provided.